排序方式: 共有6条查询结果,搜索用时 0 毫秒
1
1.
Joanne Ng MD PhD Elisenda Cortès-Saladelafont MD Lucia Abela MD Pichet Termsarasab MD Kshitij Mankad FRCR Sniya Sudhakar FRCR Kathleen M. Gorman MD Simon J.R. Heales PhD Simon Pope PhD Lorenzo Biassoni MSc FRCP FEBNM Barbara Csányi MD John Cain FRCR PhD Karl Rakshi MBChB Helen Coutts MD Sandeep Jayawant MD FRCPCH Rosalind Jefferson MBBS PhD Deborah Hughes MSc Àngels García-Cazorla MD PhD Detelina Grozeva PhD F. Lucy Raymond MD PhD Belén Pérez-Dueñas MD PhD Christian De Goede MD Toni S. Pearson MD Esther Meyer PhD Manju A. Kurian MD PhD 《Movement disorders》2020,35(8):1357-1368
2.
3.
4.
5.
6.
Albert Flotats MD FEBNM DCBNC Ignasi Carrió MD FEBNM FRCP 《Journal of nuclear cardiology》2009,16(2):304-315
The management of patients with heart failure (HF) is challenging and requires the integration of clinical skills and accurate
ancillary tests for the correct diagnosis and estimation of individual prognosis. Although the basic characterization of patients
with HF is supported primarily by echocardiographic assessment of the left ventricular function, other noninvasive imaging
procedures are being developed, including those involved in the processes of myocardial perfusion, metabolism, cellular injury,
intersticial dysregulation, and neurohormonal receptor function. Nuclear techniques for molecular imaging of the myocardium
may provide valuable insights into the pathophysiology, severity, management (medical/mechanical/surgical), response to treatment,
and prognosis of HF patients. This will permit individualized management decisions and hopefully facilitate better clinical
outcomes for patients with HF. 相似文献
1